BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou M, Xie Y, Xu S, Xin J, Wang J, Han T, Ting R, Zhang J, An F. Hypoxia-activated nanomedicines for effective cancer therapy. Eur J Med Chem 2020;195:112274. [PMID: 32259703 DOI: 10.1016/j.ejmech.2020.112274] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Dong H, Yang D, Hu Y, Song X. Recent advances in smart nanoplatforms for tumor non-interventional embolization therapy. J Nanobiotechnology 2022;20:337. [PMID: 35858896 DOI: 10.1186/s12951-022-01548-w] [Reference Citation Analysis]
2 Cong X, Chen J, Xu R. Recent Progress in Bio-Responsive Drug Delivery Systems for Tumor Therapy. Front Bioeng Biotechnol 2022;10:916952. [DOI: 10.3389/fbioe.2022.916952] [Reference Citation Analysis]
3 Zhang L, Du X, Li Q, Qian L, Chen J, Liu C, Yu Q, Gan Z. A Multimodal Therapeutic Nanoplatform Overcoming Tumor Hypoxia Heterogeneity for Improved Tumor Chemoradiotherapy. Adv Funct Materials. [DOI: 10.1002/adfm.202204629] [Reference Citation Analysis]
4 Li Y, Chen Z, Gu L, Duan Z, Pan D, Xu Z, Gong Q, Li Y, Zhu H, Luo K. Anticancer nanomedicines harnessing tumor microenvironmental components. Expert Opin Drug Deliv 2022. [PMID: 35244503 DOI: 10.1080/17425247.2022.2050211] [Reference Citation Analysis]
5 Hu Y, Gao S, Khan AR, Yang X, Ji J, Xi Y, Zhai G. Tumor microenvironment-responsive size-switchable drug delivery nanosystems. Expert Opin Drug Deliv 2022. [PMID: 35164610 DOI: 10.1080/17425247.2022.2042512] [Reference Citation Analysis]
6 Qin S, Xu Y, Li H, Chen H, Yuan Z. Recent advances in in situ oxygen-generating and oxygen-replenishing strategies for hypoxic-enhanced photodynamic therapy. Biomater Sci 2021;10:51-84. [PMID: 34882762 DOI: 10.1039/d1bm00317h] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
7 Wishart G, Gupta P, Nisbet A, Schettino G, Velliou E. On the Evaluation of a Novel Hypoxic 3D Pancreatic Cancer Model as a Tool for Radiotherapy Treatment Screening. Cancers (Basel) 2021;13:6080. [PMID: 34885188 DOI: 10.3390/cancers13236080] [Reference Citation Analysis]
8 Pierce KM, Miklavcic WR, Cook KP, Hennen MS, Bayles KW, Hollingsworth MA, Brooks AE, Pullan JE, Dailey KM. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials (Basel) 2021;11:3018. [PMID: 34835785 DOI: 10.3390/nano11113018] [Reference Citation Analysis]
9 Güçlü E, Eroğlu Güneş C, Kurar E, Vural H. Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy. Med Oncol 2021;38:113. [PMID: 34378101 DOI: 10.1007/s12032-021-01562-2] [Reference Citation Analysis]
10 Kim JY, Lee EJ, Ahn Y, Park S, Bae YJ, Kim TG, Oh SH. Cathepsin L, a Target of Hypoxia-Inducible Factor-1-α, Is Involved in Melanosome Degradation in Melanocytes. Int J Mol Sci 2021;22:8596. [PMID: 34445307 DOI: 10.3390/ijms22168596] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Anduran E, Dubois LJ, Lambin P, Winum JY. Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 - 2021. Expert Opin Ther Pat 2021;:1-12. [PMID: 34241566 DOI: 10.1080/13543776.2021.1954617] [Reference Citation Analysis]
12 Xin J, Deng C, Aras O, Zhou M, Wu C, An F. Chemodynamic nanomaterials for cancer theranostics. J Nanobiotechnology 2021;19:192. [PMID: 34183023 DOI: 10.1186/s12951-021-00936-y] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
13 Zhang Y, Coleman M, Brekken RA. Perspectives on Hypoxia Signaling in Tumor Stroma. Cancers (Basel) 2021;13:3070. [PMID: 34202979 DOI: 10.3390/cancers13123070] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
14 Shi Y, Gong M, Deng Z, Liu H, Chang Y, Yang Z, Cai L. Tirapazamine suppress osteosarcoma cells in part through SLC7A11 mediated ferroptosis. Biochem Biophys Res Commun 2021;567:118-24. [PMID: 34147710 DOI: 10.1016/j.bbrc.2021.06.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wishart G, Gupta P, Nisbet A, Velliou E, Schettino G. Novel Anticancer and Treatment Sensitizing Compounds against Pancreatic Cancer. Cancers (Basel) 2021;13:2940. [PMID: 34208295 DOI: 10.3390/cancers13122940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wishart G, Gupta P, Schettino G, Nisbet A, Velliou E. 3d tissue models as tools for radiotherapy screening for pancreatic cancer. Br J Radiol 2021;94:20201397. [PMID: 33684308 DOI: 10.1259/bjr.20201397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
17 Khot VM, Salunkhe AB, Pricl S, Bauer J, Thorat ND, Townley H. Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance. Drug Discov Today 2021;26:724-39. [PMID: 33359624 DOI: 10.1016/j.drudis.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Silva TL, de Azevedo MDLS, Ferreira FR, Santos DC, Amatore C, Goulart MO. Quinone-based molecular electrochemistry and their contributions to medicinal chemistry: A look at the present and future. Current Opinion in Electrochemistry 2020;24:79-87. [DOI: 10.1016/j.coelec.2020.06.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
19 Sawant SS, Patil SM, Gupta V, Kunda NK. Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment. Int J Mol Sci 2020;21:E7575. [PMID: 33066447 DOI: 10.3390/ijms21207575] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
20 Anduran E, Aspatwar A, Parvathaneni NK, Suylen D, Bua S, Nocentini A, Parkkila S, Supuran CT, Dubois L, Lambin P, Winum JY. Hypoxia-Activated Prodrug Derivatives of Carbonic Anhydrase Inhibitors in Benzenesulfonamide Series: Synthesis and Biological Evaluation. Molecules 2020;25:E2347. [PMID: 32443462 DOI: 10.3390/molecules25102347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]